Well Differentiated Thyroid Carcinoma: Challenges in Diagnosis
Well Differentiated Thyroid Carcinoma: Challenges in Diagnosis is organized by Opus Medicus, Inc.
Last Review Date: 12-Nov-2018
Expiration Date: 11-Nov-2021
The target audience for this medical event is Oncologists. This CME Conference has been approved for a maximum of 1.25 AMA PRA Category 1 Credits.
This course covers Fine Needle Aspiration (FNA) cytology and histology of well differentiated thyroid cancer focusing on the morphologic controversial issues of nuclear changes, capsular invasion and architectural features. It describes the role of complementary immunohistochemical and molecular testing in the diagnosis of well-differentiated thyroid cancer.
Cytopathology, Histopathology, Immunohistochemistry and Molecular Pathology of well-diferentiated thyroid carcinoma.
• Recognition of accepted morphologic features and additional studies that are diagnostic of well-differentiated thyroid cancer.
• Recognition of controversial issues in this field of Pathology that should be recognized in our daily practice.
Additional details will be posted as soon as they are available.
- CME : 1.25
- MOC : 1.25
Toll free Number
Browse CME / CE Conferences by Specialty View All
- Clinical Pharmacology
- Emergency Medicine
- Endocrinology, Metabolism and Diabetes
- Healthcare Management
- Infectious Disease
- Medical Education
- Obstetrics and Gynecology
- Pain Management
- Pharmacy and Medicine
- Primary Care
- Pulmonary Medicine